×
Home Current Archive Editorial board
News Contact

Archive

More Filters

Contents

03.05.2018. Research & Innovation Biochemistry
Producing the Triple Aim Through a TeleWound Solution

No abstract available. Author’s note: In our 25+ years in the post-acute care provider industry, we have experienced the value of integrating telehealth and remote patient monitoring into our care delivery model, which has improved our ability to care for patients at a substantially reduced cost of care. We knew that there had to be a way to ...

By Joseph F. Ebberwein, Katherine F. Piette

03.05.2018. Training Tools for Health Professionals & Patients Biochemistry
Maximizing Your Success with Telehealth

No abstract available....

By Jeffrey Jones

No abstract available. Editor’s note: Changes (some predict repeal) in the Affordable Care Act is an immanent prospect that will affect all stakeholders in healthcare, including patients, providers, and innovators in telemedicine. In this article and three others included in this issue of Telehealth and Medicine Today, David Gruber and Peter ...

By David Gruber, Peter Urbanowicz

No abstract available. Editor’s note: What follows is an abridged, illustration-rich presentation of research conducted for Project Catalyst (charged with positioning the 50+ consumer the center of innovation) by HITLAB (a healthcare innovation lab dedicated to improving the quality and accessibility of healthcare worldwide). HITLAB helps sta...

By TMT Editorial Team

03.05.2018. Commentary Biochemistry
Obamacare: Coverage without Cost Containment

No abstract available. Editor’s note: Changes (some predict repeal) in the Affordable Care Act is an immanent prospect that will affect all stakeholders in healthcare, including patients, providers, and innovators in telemedicine. In this article and three others included in this issue of Telehealth and Medicine Today, David Gruber and Peter ...

By David Gruber, Peter Urbanowicz

03.05.2018. Commentary Biochemistry
“Repeal and Replace”: What’s Next

No abstract available. Editor’s note: Changes (some predict repeal) in the Affordable Care Act is an immanent prospect that will affect all stakeholders in healthcare, including patients, providers, and innovators in telemedicine. In this article and three others included in this issue of Telehealth and Medicine Today, David Gruber and Peter ...

By David Gruber, Peter Urbanowicz

03.05.2018. Research & Innovation Biochemistry
Reducing Hospital Readmissions: A PatientBond Case Study

Readmission penalties on hospitals hit a new high in 2016, increasing by a fifth over 2015 numbers to $528 million. Yet, according to data from the Centers for Medicare & Medicaid Services (CMS), the 30-day readmission rate is on the decline. Since the Hospital Readmission Reduction Program (HRRP) began in 2010, preventable readmissions have dr...

By Brent Walker

03.05.2018. Research & Innovation Biochemistry
Telemedicine in Georgia Schools

No abstract available....

By Alexander Anthony

04.05.2018. Opinion/Perspectives/Commentary Biochemistry
The Affordability Platform: Moving Towards Outcome-based Care Delivery

No abstract available....

By Richard Bakalar, David Gruber, Joel Reich

02.05.2018. Opinion/Perspectives/Commentary Biochemistry
Reconfiguration of Healthcare for Bottom Line Results

This discussion about factors that are influencing progress in telehealth and the U.S. healthcare system was recorded on March 16, 2017, during the TMT-sponsored 1st Annual Conference: Profitable, Scalable & Sustainable Tactics Transforming Long-term Care in Telehealth and Medicine....

By David Gruber, Joseph P. McMenamin, Joel Reich